In-person cancer annual meetings during the COVID-19 pandemic: What you need to know

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Professional societies are implementing measures to limit transmission of SARS-CoV-2 at conferences, as oncology groups reconvene in-person annual meetings for the first time since early 2020. The American Society of Clinical Oncology will require proof of vaccination, encourage indoor masking, and provide masks onsite—regardless of mandates and regulations—at its upcoming annual meeting June 3-7 in...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 
Matthew Bin Han Ong
Matthew Bin Han Ong

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login